Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerold Schuler

Showing results (181-190 of 188) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 188 results.
European Journal of Cancer (Oxford, England : 1990)|April 18, 2016
Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapyLars Hofmann, Andrea Forschner, Carmen Loquai, et al.
Journal for Immunotherapy of Cancer|May 9, 2024
Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapyChristopher Lischer, Martin Eberhardt, Cindy Flamann, et al.
Oncoimmunology|September 26, 2015
Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patientsKalijn F Bol, Carl G Figdor, Erik Hjg Aarntzen, et al.
Science Immunology|August 8, 2017
Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironmentGordon F Heidkamp, Jil Sander, Christian H K Lehmann, et al.
Plos One|January 24, 2013
The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab networkCaroline J Voskens, Simone M Goldinger, Carmen Loquai, et al.
Nature Genetics|May 8, 2012
Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligoYing Jin, Stanca A Birlea, Pamela R Fain, et al.
Immunome Research|November 25, 2010
DC-ATLAS: a systems biology resource to dissect receptor specific signal transduction in dendritic cellsDuccio Cavalieri, Damariz Rivero, Luca Beltrame, et al.
Oncoimmunology|July 3, 2015
Consensus nomenclature for CD8<sup>+</sup> T cell phenotypes in cancerLionel Apetoh, Mark J Smyth, Charles G Drake, et al.
Pageof 19

Showing results (181-190 of 188) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 188 results.
European Journal of Cancer (Oxford, England : 1990)|April 18, 2016
Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapyLars Hofmann, Andrea Forschner, Carmen Loquai, et al.
Journal for Immunotherapy of Cancer|May 9, 2024
Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapyChristopher Lischer, Martin Eberhardt, Cindy Flamann, et al.
Oncoimmunology|September 26, 2015
Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patientsKalijn F Bol, Carl G Figdor, Erik Hjg Aarntzen, et al.
Science Immunology|August 8, 2017
Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironmentGordon F Heidkamp, Jil Sander, Christian H K Lehmann, et al.
Plos One|January 24, 2013
The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab networkCaroline J Voskens, Simone M Goldinger, Carmen Loquai, et al.
Nature Genetics|May 8, 2012
Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligoYing Jin, Stanca A Birlea, Pamela R Fain, et al.
Immunome Research|November 25, 2010
DC-ATLAS: a systems biology resource to dissect receptor specific signal transduction in dendritic cellsDuccio Cavalieri, Damariz Rivero, Luca Beltrame, et al.
Oncoimmunology|July 3, 2015
Consensus nomenclature for CD8<sup>+</sup> T cell phenotypes in cancerLionel Apetoh, Mark J Smyth, Charles G Drake, et al.
Pageof 19